ÂÜÀòÂÒÂ×

Tom Watson serves as the Chief Executive Officer at Bionical Emas since April 2018, leading efforts to provide life-changing treatments to patients globally. Previously, Tom held multiple positions at TW Consulting Group LLC, including Chief Operating Officer and Executive Vice President of Early Access Programs, which focused on successful pre-approval access strategies. At Clinigen Group, Tom was the Head of U.S. Business Development from September 2013 to April 2017, contributing to the global specialty pharmaceutical sector. Additionally, Tom's extensive career at Servier encompassed roles from Regional Manager to Director of Global Business Development over a span of 13 years. Tom holds a degree in Chemistry and Pharmacology from the University of Liverpool.